±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 520  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

ÈýÒ¶²ÝÍõ

Ìú³æ (ÕýʽдÊÖ)

[ÇóÖú] Ó¢ÎÄ·­ÒëÖÐÎÄ

The incidence rate of lung cancer has increased over the past decades in China in association with high mortality rates.Non-small-cell lung cancer (NSCLC) is the major histological class accounting for 80% of all lung cancers. Despite advances in multimodality therapies, surgery remains the primary treatment for NSCLC patients with generally unsatisfactory results in advanced disease. New effective therapeutic strategies are urgently needed,and further research on the molecular mechanisms underlying lung cancer is essential.
    Alterations in growth regulatory signaling pathways play an important role in the pathogenesis of NSCLC. Numerous reports have shown an association between aberrant activation of the Wingless-type (Wnt) signaling pathway and carcinogenesis including that of NSCLC . The Wnt family is a group of secreted signaling molecules that mediate a variety of cellular processes through canonical and/or noncanonical pathways .In the canonical pathway, the Wnt ligand binds directly to the cysteinerich extracellular domain of Frizzled (Fz), resulting in b-catenin stabilization and accumulation in the cytoplasm. The cytoplasmic b-catenin translocates into the nucleus and binds to Tcf/Lef transcription factors, forming a heterodimeric complex that further activates the transcription of important downstream target genes. Aberrant Wnt/b-catenin signaling has been shown to promote cancer cell growth and is associated with poor prognosis in NSCLC . Noncanonical pathways are referred to asb-catenin-independent Wnt signaling.
    The down-regulation of Wnt antagonists is a common mechanism of aberrant activation of the Wnt signaling pathway. As a major antagonist, Wnt inhibitory factor-1 (WIF-1) is silenced by promoter methylation in NSCLC. However, the mechanism underlying the over-methylation of the WIF-1 gene remains unclear. DNA methylation involves the transfer of a methyl group from the methyl donor S-adenosyl methionine to the 5
position on the cytosine ring, and is accomplished by DNA methyltransferases (DNMTs). Three catalytically active DNMTs, DNMT1, DNMT3A and DNMT3B, have been identified in mammals[8]. The mRNA levels of DNMT1, DNMT3A, and DNMT3B are reportedly elevated in various malignanciesand have been correlated with hypermethylation of tumor suppressor genes.
ÎҺܰôµÎ
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ssssllllnnnn

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

Translator and Proofreader


¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
ÕæÇ¿±ØÊ¤: ½ð±Ò+5, лл 2014-08-21 08:15:56
ÈýÒ¶²ÝÍõ: ½ð±Ò+20, ·­ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2014-08-22 18:31:10
ÔÚ¹ýÈ¥¼¸Ê®Ä꣬ÖйúµÄ·Î°©·¢²¡ÂÊÒÑÓÐÃ÷ÏÔÉÏÉý£¬²¢°éÓиßËÀÍöÂÊ¡£NSCLCÊǷΰ©µÄ×é֯ѧÀàÐÍ£¬Ô¼Õ¼ËùÒԷΰ©µÄ80£¥¡£ËäÈ»ÔÚÁªºÏÖÎÁÆ·½ÃæÈ¡µÃÁ˽øÕ¹£¬µ«ÊÖÊõÈÔÈ»ÊǷΰ©ÖÎÁƵÄÖ÷ÒªÊֶΣ¬µ«ÊÖÊõ¶ÔÍíÆÚ·Î°©ÁÆÐ§×ÜÌåÀ´ËµÊDz»ÂúÒâµÄ¡£¼±ÐèÐÂÐͶøÓÐЧµÄÖÎÁÆ´ëÊ©£¬¶ø¶ÔÒý·¢·Î°©µÄ·Ö×Ó»úÖÆµÄ½øÒ»²½Ñо¿ÓÖÊDZØÐèµÄ¡£

Éú³¤µ÷½ÚÐźÅͨ·µÄ±ä»¯ÔÚNSCLC·¢²¡»úÖÆÖз¢»ÓÖØÒª×÷Óá£Ðí¶à±¨¸æ±íÃ÷£¬WntÐźÅͨ·µÄÒì³£¼¤»îÓë°üÀ¨NSCLCÔÚÄڵݩ֢·¢²¡Ö®¼äÓйØÁª¡£Wnt¼Ò×åÓÉÒ»×é·ÖÃÚÐÍÐźŷÖ×Ó×é³É£¬¿ÉÒÔͨ¹ý¾­µä¼°·Ç¾­µä;¾¶¶ø½éµ¼Ðí¶àϸ°û¹ý³Ì¡£ÔÚ¾­µä;¾¶£¬WntÅäÌåÖ±½ÓÓëFrizzled£¨Fz£©µÄ¸»º¬°ëë×°±ËáµÄ°ûÍâÓò½áºÏ£¬µ¼Ö¦£­cateninµÄÎȶ¨ÐÔÔö¼Ó²¢ÓÚϸ°ûÖÊÖлý¾Û¡£¦Â£­cateninÓÉϸ°ûÖÊתλÈëϸ°ûºË£¬²¢ÓëTCF/LEFת¼Òò×Ó½áºÏ£¬ÐγÉÒ»Òì¾ÛÌ帴ºÏÎºóÕß½øÒ»²½¼¤»îÖØÒªÏÂÓλùÒòµÄת¼¡£ÒѾ­·¢ÏÖWnt/¦Â£­cateninÒì³£¿ÉÒÔ´Ù½ø°©Ö¢Ï¸°ûµÄÉú³¤²¢ÓëNSCLCÔ¤ºó²îÏà¹Ø¡£·Ç¾­µä;¾¶ÔòÊÇÖ¸·Ç¦Â£­cateninÒÀÀµÐÔWntÐźÅ;¾¶¡£

¶ÔWntÞ׿¹¼ÁµÄϵ÷ÊÇÒýÆðWntÐźÅͨ·Òì³£¼¤»îµÄÒ»ÖÖ³£¼û»úÖÆ¡£WntÒÖÖÆÒò×Ó£­1£¨WIF-1£©ÊÇÒ»ÖÖÖ÷ÒªµÄÞ׿¹¼Á£¬ÔÚNSCLCÖÐͨ¹ý¶ÔÆäÆô¶¯×ӵļ׻ù»¯¶ø±»¾²Ä¬¡£È»¶ø£¬ÒýÆðWIF-1»ùÒò¹ý¶È¼×»ù»¯µÄ»úÖÆÄ¿Ç°Éв»Çå³þ¡£DNA¼×»ù»¯°üÀ¨Ò»¼×»ù»ùÍÅÓɼ׻ù¹©ÌåS-ÏÙÜÕ¼×Áò°±Ëá×ªÒÆÖÁ°ûà×ऻ·Ö®µÚ5λÖ㬴˷´Ó¦ÓÉDNA¼×»ù×ªÒÆÃ¸£¨DNMTs£©Íê³É¡£ÔÚ²¸ÈéÀàÒѾ­·¢ÏÖÓÐÈýÖÖ¾ßÓд߻¯»îÐÔµÄDNMTs£¬·Ö±ðΪDNMT1, DNMT3AºÍDNMT3B¡£Óб¨¸æ±íÃ÷£¬ÔÚ¸÷ÖÖ¶ñÐÔÖ×ÁöÖÐDNMT1, DNMT3AºÍDNMT3B mRNAˮƽÌá¸ß£¬¶øÇÒÓëÖ×ÁöÒÖÖÆ»ùÒòµÄ³¬¼×»ù»¯Ïà¹Ø¡£
2Â¥2014-08-20 23:28:22
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÈýÒ¶²ÝÍõ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ÉúÎïÓëÒ½Ò©Çóµ÷¼Á +5 heguanhua 2026-04-05 6/300 2026-04-05 22:58 by Hdyxbekcb
[¿¼ÑÐ] ÉúÎïÓëÒ½Ò©µ÷¼Á +4 Ê®Æßsa 2026-04-05 4/200 2026-04-05 20:05 by lys0704
[¿¼ÑÐ] ±¾¿Æ211£¬293·ÖÇëÇóµ÷¼Á +8 Á«²Ë¾ÍÊÇź°É 2026-04-03 9/450 2026-04-05 19:12 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 306·Ö²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +7 Àè°ÉÀ²À²ÄãºÜÓÐà 2026-04-03 7/350 2026-04-05 17:18 by Hdyxbekcb
[¿¼ÑÐ] ¹¤¿Æ277·ÖÇóµ÷¼Á²ÄÁÏ +8 ÉÏÁËÉÏÁËÉÏŶ 2026-04-05 9/450 2026-04-05 13:05 by wwytracy
[¿¼ÑÐ] 290Çóµ÷¼Á085701 +10 1314Åõ»¨ 2026-04-02 10/500 2026-04-05 10:19 by Sealedwind
[¿¼ÑÐ] ר˶310Çóµ÷¼Á +5 ÀÌÀÌÎÒ¡­. 2026-04-04 6/300 2026-04-04 23:33 by barlinike
[¿¼ÑÐ] 344²ÄÁÏÓ뻯¹¤µ÷¼Á +9 µ÷¼ÁÉϰ¶«^ 2026-04-03 9/450 2026-04-04 23:10 by happyddm
[¿¼ÑÐ] 315Çóµ÷¼Á +13 СÑòСÑò_ 2026-04-02 14/700 2026-04-04 20:30 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 331Çóµ÷¼Á +3 niby 2026-04-02 3/150 2026-04-04 19:56 by À¶ÔÆË¼Óê
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖйúʯÓÍ´óѧ»¯Ñ§¹¤³Ì323·ÖÇóµ÷¼Á +4 »¯¹¤×¨Ë¶323·Ö 2026-04-03 6/300 2026-04-03 22:12 by dongzh2009
[¿¼ÑÐ] 070300Ò»Ö¾Ô¸211£¬312·ÖÇóµ÷¼ÁԺУ +16 С»ÆÑ¼±¦ 2026-03-30 16/800 2026-04-03 19:53 by lijunpoly
[¿¼ÑÐ] ר˶ 351 086100 Ò²ÊÇ¿¼µÄ²Ä¿Æ»ù ±¾¿ÆÒ²ÊDzÄÁÏ +8 202451007219 2026-04-02 8/400 2026-04-03 09:50 by À¶ÔÆË¼Óê
[¿¼ÑÐ] Ò»Ö¾Ô¸´ó¹¤Ñ§Ë¶£¬Çóµ÷¼Á +4 yub0811 2026-04-02 4/200 2026-04-02 21:36 by °ÙÁéͯ888
[¿¼ÑÐ] 279Çóµ÷¼Á +5 ¸µÎÄÇï 2026-04-02 5/250 2026-04-02 18:10 by ±ÊÂä½õÖÝ
[¿¼ÑÐ] 324Çóµ÷¼Á +5 ÏëÉÏѧÇóµ÷ 2026-04-01 6/300 2026-04-02 10:16 by sanrepian
[¿¼ÑÐ] 070300»¯Ñ§×¨Òµ279µ÷¼Á +10 ¹þ¹þ¹þ^_^ 2026-03-31 10/500 2026-03-31 23:13 by liu823948201
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷½»´ó080500²ÄÁÏѧ˶349 +6 jqx1258 2026-03-31 7/350 2026-03-31 21:08 by yuq
[¿¼ÑÐ] Ò»Ö¾Ô¸Öк£Ñó²ÄÁÏ357 +4 Âó¶÷Àò. 2026-03-30 4/200 2026-03-31 14:35 by ¼Çʱ¾2026
[¿¼ÑÐ] 297 µØÀíѧ070500 ¸´ÊÔÇóµ÷¼Á +3 СԲȦȦooo 2026-03-30 3/150 2026-03-30 21:05 by ÓàÕðyz
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û